US FDA Commissioner Scott Gottlieb’s proposal for a subscription model for hospital purchasing of antibiotics could help shore up the market, but industry experts think additional incentives are needed.
Reimbursement for antibiotics, particularly at hospitals, is among the factors limiting the antibiotic market and holding back antimicrobial research and...







